Literature DB >> 25519308

Sevoflurane Used for Color Doppler Ultrasound Examination in Children.

Conghai Fan1, Fengchao Zhang2, Xiaomei Huang1, Cheng Wen1, Chengjing Shan1.   

Abstract

The objective of this study is to investigate the feasibility of sevoflurane inhalation in pediatric color doppler ultrasound examination. In this study, 30 cases of children under 1 year were selected. They were all I or II levels according to American Society of Anesthesiology. Children with severe cyanotic congenital heart disease or severe pneumonia were excluded. All the children received anesthesia with sevoflurane. The University of Michigan Sedation Scale was assessed and bispectral index (BIS) was recorded before induction (T0), after induction (T1), when maintaining (T2), and when waking-up (T3). Blood pressure and heart rate were monitored during the color doppler ultrasound examination, the time to receive sedation examination and anesthesia recovery time were also recorded. (1) Score for UMSS was zero at T0 and 3 at T1; (2) BIS value was 93.18 ± 2.94 at T0 and decreased to 87.6 ± 3.9 at T1; (3) Blood pressure or heart rate did not decline obviously; (4) The time to receive sedation examination was 46.4 ± 13.1 s and anesthesia recovery time was 7.8 ± 5.3 min. In conclusion, sevoflurane can be used in pediatric color doppler ultrasound examination safely and effectively.

Entities:  

Keywords:  Bispectral index (BIS); Safe and effective; Sevoflurane; University of Michigan Sedation Scale (UMSS)

Mesh:

Substances:

Year:  2015        PMID: 25519308     DOI: 10.1007/s12013-014-0415-5

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  1 in total

1.  Does sevoflurane add to outpatient procedural sedation in children? A randomised clinical trial.

Authors:  Hugo Sérgio de Oliveira Gomes; Heloisa de Sousa Gomes; Joji Sado-Filho; Luciane Rezende Costa; Paulo Sucasas Costa
Journal:  BMC Pediatr       Date:  2017-03-24       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.